prof. MUDr. Jiří Mayer, CSc.
Department head, Department of Internal Medicine, Hematology and Oncology
correspondence Address:
Jihlavská 340/20, 625 00 Brno
phone: | +420 532 23 3643, 3603 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 1630
2022
-
Letermovir u pacientů po alogenní transplantaci krvetvorných buněk – přehled literatury
Transfuze a Hematologie Dnes, year: 2022, volume: 28, edition: 1, DOI
-
Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b
LEUKEMIA, year: 2022, volume: 36, edition: 5
-
Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant
British journal of haematology, year: 2022, volume: 196, edition: 3, DOI
-
Memory B-cell like chronic lymphocytic leukaemia is associated with specific methylation profile of WNT5A promoter and undetectable expression of WNT5A gene
Epigenetics, year: 2022, volume: 17, edition: 12, DOI
-
Modelling chronic lymphocytic leukaemia microenvironment.
Year: 2022, type: Conference abstract
-
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
JOURNAL OF HEMATOLOGY & ONCOLOGY, year: 2022, volume: 15, edition: 1, DOI
-
Na nejmodernější terapie současné platební modely nestačí. Ty nové se neobejdou bez dat z klinické praxe, ale kde je vzít?
Year: 2022, type: Article in Periodical (without peer review)
-
Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-A
American Journal of Hematology, year: 2022, volume: 97, edition: 11, DOI
-
Přídatné cytogenetické abnormality prokázané při diagnóze CML a jejich vliv na prognózu – analýza z databáze INFINITY
Year: 2022, type: Conference abstract
-
Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia
New England Journal of Medicine, year: 2022, volume: 386, edition: 15, DOI